These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2585974)

  • 1. [The current concept of tumor markers in oncological urology--cell surface markers].
    Ianev V; Kumanov Kh; Tsvetkov D; Ormanov I
    Khirurgiia (Sofiia); 1989; 42(4):14-7. PubMed ID: 2585974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple cell markers in bladder cancer. Principles and clinical applications.
    Javadpour N
    Urol Clin North Am; 1984 Nov; 11(4):609-16. PubMed ID: 6390912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Determination of surface ABO(H) isoantigens in transitional cell carcinoma of the bladder. Clinicopathological study. (Part 1)].
    Gelabert Mas A; Corominas J; Arango O
    Actas Urol Esp; 1988; 12(3):248-53. PubMed ID: 3177059
    [No Abstract]   [Full Text] [Related]  

  • 4. [Study of the Thomsen-Friedenreich antigen in bladder tumors].
    Fukatsu H; Yamada H; Nonomura H; Miyagawa Y; Waki M; Hatano Y; Hiraiwa S; Muramatsu T; Nishikawa E; Yamada Y
    Hinyokika Kiyo; 1988 Feb; 34(2):260-7. PubMed ID: 3376818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The study of cell surface antigens in bladder tumors: ABH-isoantigen and Thomsen-Friedenreich antigen].
    Kobayashi H
    Hinyokika Kiyo; 1987 Apr; 33(4):535-44. PubMed ID: 3618425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Behavior of the ABO(H) blood group antigens of the urothelial surface in bladder tumors].
    Proca E; Lucan M; Pîslăraşu M
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1987; 36(6):401-12. PubMed ID: 2964680
    [No Abstract]   [Full Text] [Related]  

  • 7. Tumor markers in bladder cancer.
    Huben RP
    Urology; 1984 Mar; 23(3 Suppl):10-4. PubMed ID: 6367189
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical cancer progression in urinary bladder tumors evaluated by multiparameter flow cytometry with monoclonal antibodies. Laval University Urology Group.
    Fradet Y; Tardif M; Bourget L; Robert J
    Cancer Res; 1990 Jan; 50(2):432-7. PubMed ID: 2295082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of CA-50 radioimmunoassay test in diagnosis of urologic malignancy. Tie for second place Jobst award.
    Hershman MJ; Habib NA; Ferro MA; Williamson RC; Wood CB
    Am Surg; 1987 Dec; 53(12):691-4. PubMed ID: 3480697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognostic markers in transitional carcinoma of the bladder].
    Blasco E; Gutiérrez-Hoyos A; Garrido C; Arozena F
    Arch Esp Urol; 1991; 44(1):47-52. PubMed ID: 2064423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple cell markers and flow cytometry in invasive bladder cancer.
    Javadpour N
    Prog Clin Biol Res; 1988; 260():189-201. PubMed ID: 3283759
    [No Abstract]   [Full Text] [Related]  

  • 12. Recent diagnostic modalities for bladder cancer.
    Sheinfeld J; Cordon-Cardo C; Bander NH
    Immunol Ser; 1990; 53():485-97. PubMed ID: 2151621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Markers of detection.
    Messing E
    Urol Oncol; 2007; 25(4):344-7. PubMed ID: 17628306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Conservation or loss of membrane antigens of the ABH blood group and their precursor substance. Prognostic importance for tumors of the bladder].
    Hammou JC; Fella C; Vacant J
    Acta Urol Belg; 1983; 51(1):12-7. PubMed ID: 6858793
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunologic indicators of prognosis in bladder cancer: the importance of cell surface antigens.
    Richie JP; Blute RD; Waisman J
    J Urol; 1980 Jan; 123(1):22-4. PubMed ID: 6985979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical significance of blood group antigen in sera as a tumor marker].
    Imai K; Arimura Y; Yachi A
    Nihon Rinsho; 1990 Feb; 48 Suppl():912-6. PubMed ID: 1972427
    [No Abstract]   [Full Text] [Related]  

  • 17. Expression of carbohydrate antigens (SSEA-1, sialyl-Lewis X, DU-PAN-2 and CA19-9) and E-selectin in urothelial carcinoma of the renal pelvis, ureter, and urinary bladder.
    Kajiwara H; Yasuda M; Kumaki N; Shibayama T; Osamura Y
    Tokai J Exp Clin Med; 2005 Sep; 30(3):177-82. PubMed ID: 16285609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Behavior of ABH surface antigens in superficial and invasive bladder neoplasma: inferences for the mechanism of tumor progression].
    Srougi M; Alves VA; Gayotto LC; Arap S
    Rev Hosp Clin Fac Med Sao Paulo; 1986; 41(1):24-7. PubMed ID: 3547591
    [No Abstract]   [Full Text] [Related]  

  • 19. [The study of ABH isoantigen and T (Thomsen-Friedenreich) antigen of superficial urothelial tumor].
    Sasaki K
    Hokkaido Igaku Zasshi; 1984 Nov; 59(6):679-89. PubMed ID: 6530208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early diagnosis and monitoring of superficial transitional cell carcinoma by microsatellite analysis on urine sediment.
    Bartoletti R; Dal Canto M; Cai T; Piazzini M; Travaglini F; Gavazzi A; Rizzo M
    Oncol Rep; 2005 Mar; 13(3):531-7. PubMed ID: 15706429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.